Bratislava, Slovakia, August 28th, 2026, Chainwire
altFINS j.s.a., a leading provider of proprietary crypto data analytics and AI-driven trading tools, today announced a strategic partnership with BitPath Holdings, Inc. aka Bio-Path Holdings, Inc. (OTC: BPTH) to launch Gen 2 Digital Asset Treasury (“Gen 2 DAT”) strategy.
Under the partnership, altFINS will provide institutional-grade crypto analytics, market intelligence, and active portfolio management infrastructure to support BitPath Holdings’s corporate treasury pivot. Additionally, altFINS Founder and CEO Richard Fetyko has been appointed to BitPath Holdings’ Advisory Board to spearhead its digital asset strategy.
Redefining Corporate Treasury Management
The partnership marks a significant evolution from traditional “buy and hold” digital asset treasuries (Gen 1 DATs) toward an active, multi-asset management model. While early pioneers demonstrated that cryptocurrencies belong on corporate balance sheets, single-asset strategies frequently expose enterprises to severe concentration risk and market volatility.
BitPath’s Gen 2 DAT is designed to outperform market cycles through active risk management—utilizing long and short positions and a diversified basket of projects at the intersection of blockchain and AI, including Layer 1 and Layer 2 networks, decentralized finance (DeFi), DePIN, and Real World Asset (RWA) tokenization.
To drive performance, altFINS will manage BitPath’s crypto exchange accounts and deliver weekly performance reports and strategic guidance. The strategy merges technical price trends with rigorous fundamental token metrics, adapting dynamically to market cycles and sentiment.
Strategic Alignment and Transaction Terms
To firmly align the long-term growth and success of both organizations:
- BitPath issued altFINS 2,561,822 restricted common shares, representing 4.9% of its common shares outstanding.
- BitPath has the option to invest up to two million euros in altFINS for up to a 22% ownership stake.
- altFINS will receive a 1.25% management fee on BitPath’s crypto portfolio, alongside performance bonuses tied to portfolio profits.
> Richard Fetyko, Founder and CEO of altFINS, stated: “The era of passive ‘buy and hold’ digital asset treasuries is evolving. While early pioneers proved that cryptocurrencies belong on corporate balance sheets, a Gen 1 single-asset approach exposes companies to unnecessary concentration risk and market volatility. Through our partnership with BitPath Holdings, we are setting a new standard for Gen 2 treasury management—empowering corporate balance sheets with institutional-grade analytics, active risk management, and a diversified, data-driven multi-asset strategy.”
> Vik Grover, CEO of BitPath Holdings, added: “Crypto markets are at an inflection point, driven by institutional adoption and a favorable regulatory environment in the U.S. and abroad. The scheduled September 15, 2026 Congressional Hearing on the Clarity Act and recently proposed SEC exemptions for crypto capital raises put the industry on the front burner for an explosive transformational period that will reboot our financial system using the blockchain. I believe the age of Gen 1 DATs will be eclipsed by active management and Gen 2 platforms using AI that marries technical analysis to fundamental research. I have high expectations for this Gen 2 DAT program and when combined with our crypto social network and token platform beta.mophoe.com, the value creation should be material.”
About altFINS j.s.a
altFINS j.s.a. is a cloud-based cryptocurrency market analysis and trading platform offering coin screening, interactive charting, automated chart pattern recognition, technical analysis, fundamental research, and on-chain data on a subscription basis. Platform features include:
- Crypto Screener: Scans thousands of digital assets using over 150 technical indicators.
- AI Chart Patterns: Automatically detects classic trading patterns such as triangles, wedges, and channels.
- Trading Signals: Delivers AI-based trade setups complete with entry, exit, and stop-loss levels.
- Data API: Supplies pre-computed analytics and metrics for developers and algorithmic traders.
- Trading Indicators: Advanced tooling designed to streamline systematic strategy formulation. For more information, users can visit www.altfins.com.
About BitPath Holdings, Inc. aka Bio-Path Holdings, Inc. (OTC: BPTH)
BitPath Holdings, Inc. aka Bio-Path Holdings, Inc., is a biotechnology pioneer focused on mRNA-based treatments for rare diseases, including acute myeloid leukemia (AML). Its lead product candidate, prexigebersen (Liposomal Grb2 antisense), is a neutral-charge, liposome-incorporated antisense drug designed to inhibit the protein synthesis of Grb2, which has achieved favorable outcomes in initial sample populations. While exploring partnerships, licenses, and sales for its biotechnology pipeline, the Company is strategically pivoting to cryptocurrency trading and social media investments in the global market. For more information, users can visit www.biopathholdings.com.
Contact
Lenka Fetyko
altFINS
[email protected]
Credit: Source link
